A Revolutionary Approach to Restore Immune Balance
Cellular Nanoparticle (CNP™)
Platform Technology
Cellics Therapeutics leverages the innovative and versatile Cellular Nanoparticle (CNP™) Technology to develop therapeutic nanoparticles with cell membranes, also known as Cellular Nanosponges, to cool down overreacted immune systems by neutralizing inflammatory cytokines and autoantibodies or to restore the power of immune systems by neutralizing toxins and viruses. Cellics is a privately held San Diego-based biopharmaceutical company founded by UC San Diego Professor Liangfang Zhang.